MARINUS PHARMACEUTICALS INC (MRNS) is a publicly traded company in the Unknown sector. Across all available filings, 27 corporate insiders have executed 160 transactions totaling $33.4M, demonstrating a bullish sentiment with $5.7M in net insider flow. The most recent transaction on Aug 5, 2024 involved a sale of 12,145 shares valued at $13.7K.
No significant insider buying has been recorded for MRNS in the recent period.
No significant insider selling has been recorded for MRNS in the recent period.
Based on recent SEC filings, insider sentiment for MRNS is bullish with an Insider Alignment Score of 58/100 and a net flow of $5.7M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at MARINUS PHARMACEUTICALS INC (MRNS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 27 insiders are actively trading MRNS stock, having executed 160 transactions in the past 90 days. The most active insider is Capital Life Sciences Investors, Llc Bain (Executive), who has made 5 transactions totaling $10.0M.
Get notified when executives and directors at MRNS file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Aug 5, 2024 | Braunstein Scott | Executive | Sale | 12,145 | $1.13 | $13.7K | |
| Aug 5, 2024 | Hulihan Joseph | Executive | Sale | 4,828 | $1.13 | $5.5K | |
| Aug 5, 2024 | E. Manning Martha | Executive | Sale | 3,621 | $1.13 | $4.1K | |
| Aug 5, 2024 | Pfanstiel Steven | Executive | Sale | 4,657 | $1.13 | $5.3K | |
| Aug 5, 2024 | Shafer Christina | Executive | Sale | 3,820 | $1.14 | $4.4K | |
| Jun 18, 2024 | Braunstein Scott | Executive | Award | 37,300 | $N/A | $0 | |
| Jun 18, 2024 | Pfanstiel Steven | Executive | Award | 12,733 | $N/A | $0 | |
| Jun 18, 2024 | Hulihan Joseph | Executive | Award | 10,918 | $N/A | $0 | |
| Jun 18, 2024 | E. Manning Martha | Executive | Award | 10,918 | $N/A | $0 | |
| Jun 18, 2024 | Shafer Christina | Executive | Award | 10,918 | $N/A | $0 | |
| Jun 18, 2024 | Austin Charles | Executive | Award | 2,300 | $N/A | $0 | |
| Jun 18, 2024 | Ezickson Elan | Executive | Award | 2,300 | $N/A | $0 | |
| Jun 18, 2024 | H. Z. Fischer Seth | Executive | Award | 2,300 | $N/A | $0 | |
| Jun 18, 2024 | Johnson Marvin | Executive | Award | 2,300 | $N/A | $0 | |
| Jun 18, 2024 | Nochur Sara | Executive | Award | 2,300 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 8 | $19.5M | 57.3% |
Sale(S) | 49 | $13.8M | 40.6% |
Exercise(M) | 15 | $699.9K | 2.1% |
Payment(F) | 1 | $7.1K | 0.0% |
Award(A) | 64 | $0 | 0.0% |
Other(J) | 9 | $0 | 0.0% |
Gift(G) | 1 | $0 | 0.0% |
Conversion(C) | 13 | $0 | 0.0% |
Insider activity at MARINUS PHARMACEUTICALS INC shows mixed signals across all time. While $19.5M in purchases indicates some executive confidence,$13.8M in sales balances the picture, resulting in a modest net flow of $5.7M.27 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Capital Life Sciences Investors, Llc Bain, has transacted $10.0M during this period.